Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

Name: Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 403804
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.